Skip to main content
GutCited

Beschreibung

Summary statistics and final outcome measures from the synbiotic preparation trial in diarrhea-predominant IBS are compiled.

Figure 30

Source Paper

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …

Nutrients (2020)

PMID: 32635661

DOI: 10.3390/nu12071999

Cite This Figure

![Figure 30: Summary statistics and final outcome measures from the synbiotic preparation trial in diarrhea-predominant IBS are compiled.]()

> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)
<figure>
  <img src="" alt="Summary statistics and final outcome measures from the synbiotic preparation trial in diarrhea-predominant IBS are compiled." />
  <figcaption>Figure 30. Summary statistics and final outcome measures from the synbiotic preparation trial in diarrhea-predominant IBS are compiled.<br>  Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption>
</figure>

Verwandte Evidenz

B
Bifidobacterium longum für Irritable Bowel Syndrome (IBS)

Bewertung B · 4 Studien

 B
Galactooligosaccharides (GOS) für Irritable Bowel Syndrome (IBS)

Bewertung B · 3 Studien

 B
Lactobacillus acidophilus für Irritable Bowel Syndrome (IBS)

Bewertung B · 3 Studien

 D
Fructooligosaccharides (FOS) für Irritable Bowel Syndrome (IBS)

Bewertung D · 2 Studien